Inroduction

Targeted cancer therapies are drugs that are actively involved in blocking the growth of cancer by interfering with specific molecules which are responsible for the growth, progression, and spread of cancerous cells. These therapies are also known as precision medicines. Targeted cancer therapy is different from standard chemotherapy treatment as these therapies target only cancerous cells without affecting the normal cells.

Also targeted cancer therapy block tumour cell proliferation, whereas standard chemotherapy kills the tumour cells. Recently targeted cancer therapies have gained increasing focus in anti-cancer drug development industry as these therapies forms the main branch of precision medicine i.e. a form of medicine that uses molecular diagnostic techniques to prevent, diagnose, and treat cancer.

Targeted cancer therapies market comprises of the drugs used as precision medicine for treating malignant and benign tumours. Many drugs in targeted cancer therapies have been approved by FDA to treat various types of cancer and have been commercialized, whereas numerous cancer therapies are being studied in clinical trials and many are in preclinical testing.

Targeted cancer therapies market is growing, this is attributed to increasing prevalence of various types of cancers such as lung cancer, breast cancer, colorectal cancer, prostate cancer, lymphoma, leukaemia, melanoma etc. Also increasing awareness regarding molecular diagnostic techniques such as liquid biopsy to detect malignancy is expected to drive the market for targeted cancer therapies over the forecast period.

Growing healthcare expenditure, and rising insurance coverage, aids in the revenue growth of targeted cancer therapies market. Increasing number of new targeted anti-cancerous drugs also drives the market for targeted anti-cancer drugs. However higher pricing of these drugs along with higher pricing of the molecular diagnostic tests to detect cancer is expected to hamper the growth of the targeted cancer therapies market over the forecast period.

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Get FREE Report Sample

Market Segmentation

By Therapy Type	Hormone Therapies Signal Transduction Inhibitors Gene Expression Modulators Apoptosis Inducers Angiogenesis Inhibitors Immunotherapies Monoclonal Antibodies
By Disease Indication	Gastrointestinal Lung Cancer Breast Cancer Colorectal Cancer Leukemia Lymphoma Melanoma Prostate Cancer Others
By End User	Hospitals Cancer and Radiation Therapy Centers Clinics

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

Get a Customized Version

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Regional analysis includes

North America (U.S., Canada)
Latin America (Argentina, Mexico, Brazil, Rest of Latin America)
Europe (Germany, Italy, France, U.K., Spain, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, Rest of APAC)
Middle East and Africa (Rest of MEA, S. Africa)

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert

I'm Available

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.